Evidence map›Paper›PMID 42562960›Full record

Observational studyJournal of human hypertension2026

Arterial-myocardial coupling in primary light chain amyloidosis: A prospective observational study of vascular involvement.

Alexandros Briasoulis, Raphael Patras, Dimitris Delialis, Georgios Georgiopoulos, Ioannis Petropoulos, Foteini Theodorakakou, Meletios Athanasios Dimopoulos, Efstathios Kastritis, Kimon Stamatelopoulos

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Journal of human hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alexandros Briasoulis *Department of Clinical Therapeutics, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece. alexbriasoulis@gmail.com.ORCID http://orcid.org/0000-0002-5740-9670
Raphael Patras *Department of Clinical Therapeutics, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Dimitris Delialis *Department of Clinical Therapeutics, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.ORCID http://orcid.org/0000-0002-7609-0087
Georgios Georgiopoulos *Department of Clinical Therapeutics, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Ioannis PetropoulosDepartment of Clinical Therapeutics, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Foteini TheodorakakouDepartment of Clinical Therapeutics, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Meletios Athanasios DimopoulosDepartment of Clinical Therapeutics, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Efstathios Kastritis *Department of Clinical Therapeutics, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Kimon Stamatelopoulos *Department of Clinical Therapeutics, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary light chain (AL) amyloidosis is a rare but lethal systemic disorder. Prior work suggests that vascular involvement may independently affect survival. Mechanistic data are needed to clarify its clinical role. We sought to explore vascular-cardiac interactions by examining associations between vascular and cardiac markers. We recruited 151 newly-diagnosed patients with AL amyloidosis who underwent peripheral vascular assessment including flow-mediated dilation (FMD) and pulse wave velocity (PWV). Transthoracic echocardiography was performed in all patients, and cardiac magnetic resonance (CMR) in a subgroup (n = 59). Ventricular-arterial coupling was assessed using PWV/global longitudinal strain (GLS), central systolic blood pressure (CSBP)/GLS, and tricuspid annular plane systolic excursion (TAPSE)/right ventricular systolic pressure (RVSP). Vascular and hemodynamic markers were associated with cardiac involvement, including left ventricle (LV) and right ventricle (RV) systolic and diastolic function, LV hypertrophy and CMR parameters (T2 and late gadolinium enhancement). Markers of vasodilation and low peripheral resistance correlated with more severe cardiac involvement. Low peripheral and central blood pressure and pressure-strain indices predicted worse survival. Peripheral vascular dysfunction was linked to adverse cardiac structure and function in AL amyloidosis. These observational findings suggest that arterial-myocardial uncoupling parallels disease severity and serves as a marker of advanced cardiovascular involvement highlighting its prognostic significance.

Indexed as

Immunoglobulin Light-chain AmyloidosisAgedEchocardiographyFemaleGlobal Longitudinal StrainHumansMaleMiddle AgedProspective StudiesPulse Wave AnalysisVascular StiffnessVentricular Function, Right

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.